Literature DB >> 21922297

An association between corticosteroid use and melanoma recurrence: a case report and review of the literature.

Mark Lazarus1, Howard Kaufman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922297     DOI: 10.1007/s12032-011-0064-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  7 in total

1.  T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas.

Authors:  M A Lowes; G A Bishop; K Crotty; R S Barnetson; G M Halliday
Journal:  J Invest Dermatol       Date:  1997-06       Impact factor: 8.551

2.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 3.  Glucocorticoids, lipocortins and the immune response.

Authors:  N J Goulding; P M Guyre
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

4.  Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.

Authors:  S K Arya; F Wong-Staal; R C Gallo
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Authors:  Alina Burgi; Stephanie Brodine; Scott Wegner; Mark Milazzo; Mark R Wallace; Katherine Spooner; David L Blazes; Brian K Agan; Adam Armstrong; Susan Fraser; Nancy F Crum
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

6.  Cutaneous malignant melanoma after Hodgkin's disease.

Authors:  M A Tucker; D Misfeldt; C N Coleman; W H Clark; S A Rosenberg
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

7.  Non-melanoma skin cancers and glucocorticoid therapy.

Authors:  M R Karagas; G L Cushing; E R Greenberg; L A Mott; S K Spencer; D W Nierenberg
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.